Skip to content

Concussion in Motor Vehicle Accidents: The Concussion Identification Index

Concussion in Motor Vehicle Accidents: The Concussion Identification Index

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02858544
Acronym
CIDI
Enrollment
1790
Registered
2016-08-08
Start date
2013-11-30
Completion date
2016-06-30
Last updated
2016-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor Vehicle Accidents, TBI (Traumatic Brain Injury), Brain Contusion, Brain Injuries, Cortical Contusion, Concussion Mild, Cerebral Concussion, Brain Concussion, Accidents, Traffic, Traffic Accidents, Traumatic Brain Injury With Brief Loss of Consciousness, Traumatic Brain Injury With no Loss of Consciousness, Traumatic Brain Injury With Loss of Consciousness

Keywords

Mild traumatic brain injury

Brief summary

The primary goal of this study is to provide clinicians with a brief, patient self-administer instrument yielding a single composite score that reliably correlates with objective findings on standardized neurocognitive assessment for concussion.

Detailed description

This Phase 2 study, Concussion in Motor Vehicle Accidents - The Concussion Identification Index (CIDI), focuses on the psychometric properties of the relationship between acute injury events, i.e. head impact, loss of consciousness (LOC), and post-traumatic amnesia (PTA), commonly reported post-crash signs and symptoms, and neurocognitive outcomes. Cohort 1 is the validation group and will be used to confirm the optimal cut-off score of the Concussion Identification Index (CIDI) with the score on the ImPACT. Cohort 2 is the cross-validation group.

Interventions

OTHERThe Concussion Identification Index

Patient completion of the Concussion Identification Index, a report of crash characteristics, injuries sustained, and post-accident neurological signs and symptoms

OTHERImPACT

Patient- completed computerized neurocognitive test battery

Sponsors

Clionsky Neuro Systems Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients injured in a motor-vehicle related accident

Exclusion criteria

* Age younger than 10 years old or older than 60 years of age * Patients who presented for initial evaluation of injuries greater than 90 days after MVA occurred * Patients who declined to take a computerized neurocognitive test battery * Patients who were not fluent in either English or Spanish

Design outcomes

Primary

MeasureTime frame
Correlation - Concussion Identification Index score with ImPACT test scoreWithin 90 days of the accident

Secondary

MeasureTime frameDescription
Patient-completed one page questionnaireWithin 90 days of the accidentThe questionnaire is divided into two parts: The Injury Characteristics section: asks for a yes-no indication of whether 5 concussion-associated events/injuries occurred: striking the head, whiplash, loss of consciousness, being dazed, or having post-traumatic amnesia; and, whether or not the patient had already been given a diagnosis of concussion. The Concussive Symptoms section asks the patient to rate on a scale of 0-3 the presence and severity of 10 cognitive and emotional symptoms associated with a post-concussion diagnosis. The total numeric value for each patient is reported as an indexed score.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026